Field Medical announced that it closed a Series A financing round worth $40 million to support its pulsed field ablation (PFA) technology. Cardiff-by-the-Sea, California–based Field Medical was founded by Dr. Steven Mickelsen, the founder of Farapulse. Mickelsen also serves as CEO. He led his previous PFA technology developer to an acquisition … [Read more...] about Field Medical raises $40M Series A for pulsed field ablation tech
Business
Spectrum Vascular bolsters executive team with new CEO, CCO
Spectrum Vascular announced today that it added to its executive team with the appointment of Ken Miller as CEO and Doug Shook as CCO. The company said its leadership appointments help advance its mission to deliver improved patient outcomes and scale impact. They build upon recent momentum, according to a news release, following a strategic … [Read more...] about Spectrum Vascular bolsters executive team with new CEO, CCO
Surmodics launches Pounce XL thrombectomy system
Surmodics (Nasdaq:SRDX) announced today that it commercially launched the Pounce XL thrombectomy system for clot removal. Pounce XL joins the larger suite of Pounce thrombectomy systems. They offer rapid endovascular removal of acute or chronic clot from peripheral arteries. Eden Prairie, Minnesota-based Surmodics designed Pounce to enable … [Read more...] about Surmodics launches Pounce XL thrombectomy system
VVT Medical plans to go public on Toronto exchange
VVT Medical, a developer of minimally invasive treatments for venous insufficiency, announced that it has received conditional approval from the TSXv to list its common shares. The Kfar Saba, Israel–based company has already secured $6.5 million in funding toward its listing and seeks to reach at least $8 million in total financing. DXI Capital … [Read more...] about VVT Medical plans to go public on Toronto exchange
Supira Medical closes $120M Series E, completes enrollment in ventricular assist device study
Supira Medical announced today that it completed an oversubscribed Series E financing round, bringing in $120 million. The clinical-stage Shifamed portfolio company also recently completed enrollment for its U.S. SUPPORT I Early Feasibility Study (EFS) evaluating its percutaneous ventricular assist device (pVAD) for treating high-risk … [Read more...] about Supira Medical closes $120M Series E, completes enrollment in ventricular assist device study
Evident Vascular closes Series B for AI-powered intravascular ultrasound
Evident Vascular announced today that it closed a Series B financing round to support its AI-powered intravascular ultrasound (IVUS) platform. The San Jose, California–based company did not disclose the amount raised in the Series B round. It adds to $35 million picked up in a Series A that brought the company out of stealth mode in 2023. … [Read more...] about Evident Vascular closes Series B for AI-powered intravascular ultrasound
Perfuze wins FDA nod for access catheter, raises $24M
Perfuze announced today that it received FDA 510(k) clearance for its Zipline access catheter and secured significant funding. The Galway, Ireland–based medtech company picked up about $24 million (€22 million) in a follow-on funding round. Existing investors, including Earlybird, EQT Life Sciences, Seroba and SV Health, participated in the … [Read more...] about Perfuze wins FDA nod for access catheter, raises $24M
NanoVibronix announces reverse stock split
NanoVibronix (Nasdaq:NAOV) announced today that it intends to effect a reverse stock split of its common stock. The split comes at a ratio of one post-split share for every 11 pre-split shares. Tyler, Texas-based NanoVibronix expects the split to go into effect at 4:05 p.m. on March 13, 2025. It plans for its common stock to continue trading on … [Read more...] about NanoVibronix announces reverse stock split
Reflow Medical expands global reach with European subsidiary
Reflow Medical announced today that it opened a European subsidiary in Landsberg am Lech, Germany, to expand outside the U.S. The company said its strategic expansion strengthens its international presence and enhances its ability to serve markets globally. SVP and GM Knut Saurteig leads the subsidiary, called Reflow Medical Europe GmbH. … [Read more...] about Reflow Medical expands global reach with European subsidiary
FTC challenges private equity firm’s acquisition of Surmodics
The U.S. Federal Trade Commission (FTC) has sued to block the planned acquisition of medical device company Surmodics by GTCR. According to a news release, GTCR also owns a majority stake in Biocoat. The FTC says Biocoat is the second-largest provider of outsourced hydrophilic medical device coatings, behind only Surmodics. As a result, the FTC … [Read more...] about FTC challenges private equity firm’s acquisition of Surmodics
